Patients Perceive Clinical Benefit with the Specific Carbohydrate Diet for Inflammatory Bowel Disease
Abstract
Background Recent studies suggest that dietary therapy may be effective for patients with inflammatory bowel disease (IBD), but limited published data exist on the usage and efficacy of dietary therapy.
Suskind, D. L., Wahbeh, G., Cohen, S. A., Damman, C. J., Klein, J., Braly, K., Shaffer, M., & Lee, D. (2016). Patients Perceive Clinical Benefit with the Specific Carbohydrate Diet for Inflammatory Bowel Disease. Digestive Diseases and Sciences, 61(11), 3255–3260. https://doi.org/10.1007/s10620-016-4307-y
Individuals perceived clinical improvement on the SCD. Four percent reported clinical remission prior to the SCD, while 33 % reported remission at 2 months after initiation of the SCD, and 42 % at both 6 and 12 months. For those reporting clinical remission, 13 % reported time to achieve remission of less than 2 weeks, 17 % reported 2 weeks to a month, 36 % reported 1-3 months, and 34 % reported greater than 3 months. For individuals who reported reaching remission, 47 % of individuals reported associated improvement in abnormal laboratory values.
Support our Mission
Your donation will help us to enhance the well-being and health outcomes of patients with IBD.
Donate